Trellis Rx Furthers Commitment to Advancing the Specialty Pharmacy Practice and Patient Outcomes with Integration of Scipher Medicine® PrismRA® Precision-Medicine Technology into Clinical Pathways
12 oct. 2021 08h00 HE
|
Scipher Medicine Corporation
ATLANTA and WALTHAM, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Trellis Rx, a leading technology-enabled specialty pharmacy services provider, today announced the integration of PrismRA®, a diagnostic...
UPDATE - Scipher Medicine Welcomes Sam Davis as General Counsel
24 sept. 2021 12h00 HE
|
Scipher Medicine Corporation
WALTHAM, Mass., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announced the appointment of Sam A....
Scipher Medicine Welcomes Sam Davis as General Counsel
24 sept. 2021 09h00 HE
|
Scipher Medicine Corporation
WALTHAM, Mass., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announced the appointment of Sam A....
Scipher Medicine Welcomes John Strumbos as Chief Financial Officer
22 sept. 2021 10h50 HE
|
Scipher Medicine Corporation
WALTHAM, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announced the appointment of John...
Scipher Medicine Welcomes Chip Parkinson as Chief Commercial Officer of its Diagnostics Business
20 sept. 2021 11h11 HE
|
Scipher Medicine Corporation
WALTHAM, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with the most effective therapy, today announces the addition of Chip Parkinson...
Ventegra Partners with Scipher Medicine For Patient-Centric Approach To Improve Outcomes and Lower Costs for Rheumatoid Arthritis Care
16 sept. 2021 08h00 HE
|
Scipher Medicine Corporation
WALTHAM, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapy, today announced a partnership with Ventegra,...
Scipher Medicine Increases Patient Access for Prismra® by Expanding Intended Use in Autoimmune Patients
29 juil. 2021 09h22 HE
|
Scipher Medicine Corporation
Expanded intended use for the blood test validated in Network-004 study.Now, most rheumatoid arthritis patients can be tested at any point in their clinical journey.Test enables providers to identify...
Scipher Medicine Announces PrismRA® Met Primary and Secondary Endpoints in Prospective Observational Study Predicting Inadequate Response to World’s Largest-Selling Drug Class
24 juin 2021 08h00 HE
|
Scipher Medicine Corporation
Blood Test Predicts TNFi Response in Patients Both Naïve to and Experienced with TherapyProviders Can Access Patient-Specific Data for Optimized Therapy Selection WALTHAM, Mass., June 24, 2021 ...
Scipher Medicine Presents New Data at the European League Against Rheumatism (EULAR) 2021 Further Validating PrismRA® Test
15 juin 2021 08h00 HE
|
Scipher Medicine Corporation
Molecular signature test predicts likelihood of non-response to adalimumab or etanercept, two of the world’s most expensive medications, in an independent validation cohort PrismRA demonstrates a more...
Scipher Medicine and Leading Medical Researchers in Network and Data Science Compress Time to Identify COVID-19 Treatments From Years to Months
08 juin 2021 08h00 HE
|
Scipher Medicine Corporation
Study demonstrates Scipher Medicine’s ability to analyze patient data to identify novel treatments.Scipher will focus on pharma collaborations in autoimmune diseases. WALTHAM, Mass., June 08, 2021 ...